Cytokinetics

Price & Volume

Track all markets on TradingView

Stats

See more
52W Range
$29.31-$70.98
Market Cap
$7.6B
Shares Short
14M

Financials

See more
Revenue (12 Mos)
$88M
Revenue Growth (YoY)
4.9%
Gross Profit (12 Mos)
-$327.9M
Diluted EPS
-$6.30

News

See more

Yahoo Finance • 4 days ago

Cytokinetics aims for over 50% new patient share for MYQORZO by end of 2026 as global commercial launch accelerates

Yahoo Finance • 12 days ago

Cytokinetics Announces European Commission Approval of MYQORZO® (aficamten) for the Treatment of Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy

Yahoo Finance • 25 days ago

Cytokinetics, Incorporated (CYTK): A Bull Case Theory

Yahoo Finance • 2 months ago

Attention Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Holley Inc. (NYSE: HLLY); Molina Healthcare, Inc. (NYSE: MOH); and WEBTOON Entertainment, Inc. (NASDAQ: WBTN): Grabar Law Office Investigates Claims on Your Behalf

About

CEO
Mr. Robert I. Blum
CFO
Mr. Sung H. Lee
Address
350 Oyster Point Boulevard, South San Francisco, CA, United States, 94080
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
498